Table 1.
U.S. Sample |
Danish Sample |
|||
---|---|---|---|---|
Case | Control | Case | Control | |
Sample size n (%) | 124 (51.2) | 118 (48.8) | 239 (51.3) | 227 (48.7) |
Rs157580 A/A (%) | 50 (40.3) | 45 (38.1) | 108(45.2) | 100 (44.1) |
Rs157580 A/G (%) | 58 (46.8) | 59 (50.0) | 96 (40.2) | 97 (42.7) |
Rs157580 G/G (%) | 16 (12.9) | 14 (11.9) | 35 (14.6) | 30 (13.2) |
MAFs | 0.36 | 0.37 | 0.35 | 0.35 |
Age (years)a | 63.2 ± 13.1b | 59.4 ± 14.3b | 48.8 ± 5.7 | 48.7 ± 6.1 |
Females/males (n) | 89/35 | 88/30 | 0/239 | 0/227 |
Medication use (n) | 58 | 45 | 12 | 4 |
TG (mg/dL) | 121.8 ± 69.1 | 126.4 ± 85.4 | 146.0 ± 99.1 | 142.7 ± 110.4 |
MAFs = minor allele frequencies, TG = triglycerides.
Shown as mean ± standard deviation.
Significantly different between caregiver and controls at a level of 0.05.